Personally, I’m in the middle of the road in reg

Personally, I’m in the middle of the road in regards to the outcome of this CC. Besides the CC in December, when the Vyera deal was announced, these CCs haven’t resulted in much. Each CC seems to give investors a new trail to follow, but rarely deceivers in terms of a definitive event (BLA submission, etc.). Although I can’t deny some excitement because NP always has some new rid but up his sleeve that keeps us talking for a few weeks and diverts are focus from the BLA delay.

Here’s my question: why isn’t the headline an update on the corona virus trial in China? Not many cases of corona virus in the U.S. and I’m sure all the BPs are fighting over treating those cases.